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Obesity induces local/systemic inflammation accompanied by increases in macrophage 
infiltration into adipose tissue and production of inflammatory cytokines, chemokines, 
and hormones. Previous studies have shown that probiotics could improve the intestinal 
dysbiosis induced by metabolic diseases such as obesity, diabetes, and metabolic syn-
drome. Microorganisms could (directly or indirectly) affect adipokine levels due to their 
capacity to induce translocation of several intestinal microbial antigens into systemic 
circulation, which could lead to metabolic endotoxemia or produce immunomodulation 
in different organs. The aim of the present study was to select non-inflammatory lactic 
acid bacteria (LAB) strains with the capacity to modulate adipokine secretion by the 
adipose tissue. We wish to elucidate the role of potential probiotic strains in the reg-
ulation of the cross talking between immune cells such as macrophages and adipose 
cells. Mouse macrophage cell line RAW 264.7 was used for evaluating the ability of 14 
LAB strains to induce cytokine production. The LAB strains were chosen based on their 
previously studied beneficial properties in health. Then, in murine adipocyte culture and 
macrophage–adipocyte coculture, we determined the ability of these strains to induce 
cytokines and leptin secretion. Tumor necrosis factor alpha, interleukin 6 (IL-6), IL-10, 
monocyte chemoattractant protein-1, and leptin levels were measured in cell superna-
tants. We also performed the detection and quantification of leptin receptor (Ob-Rb) 
expression in macrophage cell lines stimulated by these LAB strains. Differential secre-
tion profile of cytokines in macrophage cells induced by LAB strains was observed. Also, 
the levels of Ob-Rb expression diverged among different LAB strains. In LAB-stimulated 
coculture cells (adipocytes and macrophages), we observed differential production of 
leptin and cytokines. Furthermore, we detected lower production levels in single culture 
than cocultured cells. The principal component analysis showed an association between 
the four clusters of strains established according to their inflammatory profiles and leptin 
adipocyte production and leptin receptor expression in macrophages. We conclude that 
coculture is the most appropriate system for selecting strains with the ability to modulate 
adipokine secretion. The use of microorganisms with low and medium inflammatory 
properties and ability to modulate leptin levels could be a strategy for the treatment of 
some metabolic diseases associated with dysregulation of immune response.
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inTrODUcTiOn
Since the discovery of leptin, 21 years ago (1), the adipose tissue 
was the focus of several functional studies, in such a way that 
nowadays it could be considered as a potent endocrine and 
immune organ (2–5). This feature is due to the peculiarity of the 
different cells that form this tissue: adipocytes, preadipocytes, 
endothelial cells, fibroblasts, and numerous immune cells 
including macrophages, B cells, T cells, and neutrophils mainly. 
The cross talk between these cells affects the composition of the 
adipose tissue-produced molecules (6, 7). By means of these 
molecules, called adipokines, the adipose tissue influences the 
regulation of several important physiological functions such as 
appetite, satiety, energy expenditure, insulin sensitivity and secre-
tion, glucose and lipid metabolism, fat distribution, endothelial 
function, blood pressure, neuroendocrine regulation, and 
immune function. Under conditions of adipose tissue dysfunc-
tion, frequently associated with obesity or undernourishment, 
the secretion of adipokines is dysregulated, affecting physiologi-
cal functions and the host’s health (8–13). Currently, more than 
600 adipokines are known. The most studied ones include leptin, 
adiponectin, resistin, visfatin, plasminogen activator inhibitor-1, 
tissue factor, tumor necrosis factor alpha (TNF-α), transforming 
growth factor beta, monocyte chemoattractant protein-1 (MCP-
1), interleukin 6 (IL-6), and IL-8 (9). Leptin and adiponectin 
are adipose-derived factors with particular interest due to their 
potential as therapeutics in obesity treatment (14). Syndromes 
of malnutrition associated with excess/lack or dysfunction of 
adipose tissue certainly belong to these kinds of diseases (10).
Previous studies showed that adipokine levels could be 
affected by changes in the gut structure or in the composition of 
microbiota (13). Scientific evidence from both animal and human 
studies supports the relationship between the composition and 
function of intestinal microbiota and the alterations observed 
in metabolic and inflammatory syndromes. Consequently, the 
design of more effective dietary strategies for improving the 
treatment and prevention of metabolic diseases via modification 
of the gut microbiota composition or function is of increasing 
interest (15). In this context, Cani et al. (16) reported that changes 
in gut microbiota (following a high-fat diet or genetically induced 
obesity) contribute to increased gut permeability, metabolic 
endotoxemia [higher serum lipopolysaccharide (LPS) levels], and 
low-grade inflammation-induced metabolic disorders (insulin 
resistance and diabetes), while its restoration by prebiotic and 
probiotic strategies ameliorate those adverse effects. Potential 
probiotic strains have been shown to play a role in nutritional 
disorders, including both under and overnutrition in human and 
animal studies (17–25).
In this context, we demonstrated that oral administration of 
potential probiotic bacteria to a high-fat diet-induced obesity 
mice model ameliorates the alterations of leptin and cytokine 
levels along with partial restoration of the obesity-induced dys-
biosis (21, 22). Recently, in vitro and in vivo studies demonstrated 
the influence of lactobacilli and bifidobacteria on adipokine levels 
(18, 21, 26). Considering the pleiotropic role of leptin in energy 
balance, the administration of commensal bacteria able to regu-
late its secretion and function could be an attractive strategy for 
the management of malnutrition (undernutrition and obesity), 
but appropriate strains need to be selected (27).
Circulating levels of leptin, an adipocyte-secreted hormone, 
are decreased or increased in undernutrition or obesity, respec-
tively, and have thus been proposed to be a link between nutri-
tional status and immune function (28–30). Papathanassoglou 
et  al. (31) suggested the notion that nutritional status, acting 
via leptin-dependent mechanisms, may alter the nature and 
vigor of the immune response. Moreover, these authors showed 
that Ob-Rb, the leptin receptor, is expressed in normal mouse 
lymphocyte subsets and that leptin plays a role in lymphocyte 
survival, which alters the Ob-Rb/STAT-3-mediated signaling 
in T cells (31). In addition, it has been suggested that microbial 
products associated with immunobiotics (immunoregulatory 
probiotics) can also cross the intestinal barrier, being able to 
modulate distant tissues (such as adipose tissue) through the 
induction of changes in cytokine profiles (32). Miyazawa et  al. 
in an in vitro study using conditioned medium showed that dif-
ferent lactobacilli may suppress differentiation of preadipocytes 
through macrophage activation and alter the immune responses 
of macrophages to adipose cells (33).
Therefore, we consider significant to establish a suitable crite-
rion for the selection of immunobiotic strains with anti-inflam-
matory properties and ability to modulate leptin production. 
These bacterial capacities in this “next-generation of probiotics” 
would be useful to be applied in alternative treatments for dis-
eases in which the profile of adipokines is deregulated (obesity, 
metabolic syndrome) (27).
The aim of the present study was to select non-inflammatory 
lactic acid bacteria (LAB) strains with capacity to modulate 
adipokine secretion in the adipose tissue. The LAB strains were 
selected for this study by their probiotic properties previously 
determined (17, 23, 34–38). To achieve this purpose, first we 
evaluated in murine macrophages the ability of different strains 
to induce the secretion of cytokines and chemokines (pro-
inflammatory and anti-inflammatory responses) involved in 
metabolic inflammation (TNF-α, IL-6, IL-10, and MCP-1). The 
infiltration of adipose tissue by macrophages is an important 
event causing increased inflammatory process in obesity (39–41). 
In addition, leptin and cytokines and one chemokine secretion 
in murine adipocytes (mono- and coculture with macrophages) 
were investigated in order to understand the role of potential pro-
biotic strains in the adipokine modulation. We also evaluated the 
leptin receptor (Ob-Rb) expression in macrophages, a molecule 
constitutively expressed in immune cells such as macrophages, 
B cells, and T cells (31).
MaTerials anD MeThODs
Bacterial strains and culture conditions
Lactic acid bacteria strains were obtained from the Centro de 
Referencia para Lactobacilos (CERELA, Tucumán, Argentina) 
culture collection. They were isolated in our laboratory from 
regional products and stools of healthy infants. All the employed 
bacteria used in this work could potentially be considered as pro-
biotic strains or as starter cultures for meat or milk fermentation. 
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Probiotic properties previously determined were immunomodu-
lation, production of conjugated linoleic acid, feruloyl esterase 
activity, protection against intestinal infections, etc (17, 23, 
34–38).
Strains used in this study were Lactobacillus casei CRL431, 
L. acidophilus CRL258, L. acidophilus CRL1063, L. casei CRL66, 
L. casei CRL72, L. casei CRL117, L. fermentum CRL1446, Lacto­
coccus lactis CRL1434, L. plantarum CRL350, L. plantarum CRL352, 
L. plantarum CRL353, L. plantarum CRL355, L. paracasei 
CRL575, and L. rhamnosus CRL576.
Bacteria were cultured in Man–Rogosa–Sharpe (MRS) broth 
(Britania, Buenos Aires, Argentina) at 37°C for 22  h (station-
ary growth phase). Cells were harvested by centrifugation 
(10,000 rpm for 10 min), washed twice with phosphate-buffered 
saline (PBS, 130 mM sodium chloride, 10 mM sodium phosphate, 
pH 7.4), and re-suspended in PBS containing 20% (v/v) glycerol. 
Aliquots of these suspensions were frozen and stored at −80°C 
until used for in vitro stimulation of macrophage and adipocyte 
cells. The number of viable cells after freezing and thawing was 
determined by colony-forming unit counting on MRS agar after 
48 h incubation in microaerophilia. For each strain tested, more 
than 90% cells remained alive upon thawing, and no significant 
differences were found during storage time (2 months). One fresh 
aliquot was thawed for every new experiment to avoid variability 
in the viability of cultures in the experiments.
ability of laB strains to induce cytokine 
secretion by Macrophages
Mouse macrophage cell line RAW 264.7 was used for evaluating 
the ability of different LAB strains to induce cytokine production 
as previously determined (21). Cells were cultured overnight 
into 24-well flat-bottom polystyrene microtiter plates (Costar® 
24 Well Clear TC-Treated Multiple Well Plates, Individually 
Wrapped, Sterile #3524) at a concentration of 1 × 105 cells per 
milliliter in Dulbecco’s Modified Eagle’s Medium (DMEM—
Gibco #41965-039). Medium was changed before stimulation, 
and then cells were incubated in the presence of 100 μl of a cell 
suspension (1 ×  107  CFU/ml) of each strain for 24  h. Purified 
LPS from Escherichia coli serotype O26: B6 (Sigma Chemical Co, 
USA, #L2654) was used as a positive control, at a final concentra-
tion of 1 μg/ml. Cell viability was assessed by the Trypan blue 
assay. Non-stimulated Raw 264.7 cells were also evaluated as 
controls of basal cytokine production (control negative). The cell 
culture supernatants were collected, centrifuged (10,000 rpm for 
10 min), and stored at −20°C until cytokine determination.
Detection and Quantification of Obesity 
receptor (Ob-rb) expression
Macrophages were collected by vigorous pipetting after stimula-
tion with different bacterial strains and immediately washed 
twice with PBS. Cells (106) were incubated with primary poly-
clonal antibody rabbit antimouse leptin receptor (Ob-R H300: 
sc8325, Santa Cruz Biotechnology, Inc.) in PBS-bovine serum 
albumin (1% w/v), dilution 1/250 (v/v) for 1  h at room tem-
perature, washed twice with PBS-BSA (5%, w/v), and incubated 
with FITC-conjugated secondary antibodies goat antirabbit 
IgG-FITC (IgG-FITC: sc-2012 Santa Cruz Biotechnology, Inc.) 
for an additional 1  h at room temperature in darkness. Cells 
were washed twice and resuspended in 500 μl PBS (1%, w/v). 
LPS-stimulated and non-stimulated macrophages were used as 
positive and negative controls of the leptin receptor expression. 
Macrophage Ob-Rb (+) was quantified using flow cytometry 
(BD/FACSCalibur). Gates were set to exclude cell debris and 
non-specific Ab binding, and results were analyzed using the 
FACS analysis software (CellQuest; BD Biosciences). Unstained 
controls were used for setting compensation and gates.
Immunofluorescence microscopy was used to detect the 
Ob-Rb leptin receptor in the macrophages. The cells were cul-
tured overnight into 24-well flat-bottom polystyrene microtiter 
plates [Costar® 24 Well Clear TC-Treated Multiple Well Plates, 
Individually Wrapped, Sterile (Product #3524)] containing glass 
coverslips 12 mm in diameter, at a concentration of 105 cells per 
milliliter in DMEM, then, the cells were washed twice with PBS 
1× and fixed with paraformaldehyde 1% (SIGMA P6148-500G) 
in PBS, and incubated with primary and secondary antibodies as 
previously described for flow cytometry. Finally, a drop of mount-
ing medium (SIGMA F4680, USA) was placed on the labeled cells 
and then the coverslip, following visualization in a fluorescence 
microscope (Carl Zeiss—Axio Scope.A1).
isolation of Murine adipocytes
Adipocytes from epididymal adipose tissue were isolated from 
6-week old Balb/c male mice by collagenase digestion (collagenase 
from Clostridium histolyticum Type II #C6885 SIGMA, USA) as 
previously described (42, 43). Briefly, adipose tissues from four to 
six mice were pooled for adipocyte isolation. Tissue was digested 
during an hour incubation period at 37°C in DMEM high glucose 
supplemented with 10% (v/v) fetal bovine serum (FBS), penicil-
lin/streptomycin, and containing 1.5 mg/ml collagenase II under 
constant agitation. The suspension was subsequently centrifuged 
at 500 rpm for 5 min at room temperature. The mature adipocyte 
floated to the surface, and the stromal vascular cells (capillary, 
endothelial, mast, macrophage, and epithelial cells) were depos-
ited at the bottom. The stromal vascular cells were removed by 
aspiration, and the fat cells were washed with 10 ml of DMEM 
high glucose supplemented with 10% FBS and penicillin/strep-
tomycin and centrifuged at 400 rpm for 2 min. This procedure 
was repeated twice. Two aliquots (10 μl) of cell suspension were 
stained with Trypan blue and counted on a hemocytometer to 
estimate the concentration of adipocyte cells. The experimental 
protocol was approved by the Animal Protection Committee of 
CERELA (CRL-BIOT-EF-2012/2A) and complied with current 
Argentinean laws.
ability of laB strains to induce cytokine 
and leptin secretion by Murine 
adipocytes culture and Macrophage-
adipocyte coculture
Adipocyte Culture
Adipocyte cells in 0.5  mL of plating medium were inoculated 
into 24-well plates at a concentration of 5 ×  105 cells/wells, to 
study the ability of different strains to induce leptin and cytokine 
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production. The cells were maintained in a humidified 5% CO2 
atmosphere for 24 h at 37°C. Medium was changed before the 
LAB stimulation, and then adipocytes were incubated in the pres-
ence of 100 μl of a cell suspension 1 × 107 CFU/ml of each strain 
for 24 h. Purified LPS from E. coli serotype O26:B6 was used at 
a concentration of 1 μg/ml as a positive control. Non-stimulated 
adipocytes cells were also evaluated as controls of basal leptin 
and cytokine production (control negative). Cell viability was 
assessed by the Trypan blue assay.
Macrophage–Adipocyte Coculture
Experiments of murine adipocytes and macrophages (cell line 
RAW 264.7) were performed by triplicate in two independ-
ent experiments with each strain. Adipocytes were seeded at a 
concentration of 104 cells/ml into 24-well plates, and macrophage 
cells were previously cultured at a concentration of 104 cells/ml. 
The cells were cocultured in a humidified 5% CO2 atmosphere 
for 24  h at 37°C. Media were changed before stimulation, and 
then cells were incubated in the presence of 100 μl of each strain 
suspension (1 × 107 CFU/ml) during 24 h at 37°C in a humidified 
5% CO2 atmosphere. Purified LPS from E. coli serotype O26:B6 
was used at a concentration of 1 μg/ml as a positive control. Non-
stimulated coculture cells were also evaluated as controls of basal 
leptin and cytokine production (control negative). The coculture 
supernatants were collected and stored at −20°C until cytokines, 
chemokine, and leptin were quantified.
Detection of Cytokines and Adipokines
Tumor necrosis factor alpha, IL-6, MCP-1, and IL-10 were quan-
tified in cell supernatants using the BD™ Cytometric Bead Array 
Mouse Inflammation Kit (BD Bioscience, 560485, San Diego, CA, 
USA). Leptin concentrations were measured in cell supernatants 
with a DuoSet kit (R&D Systems, Minneapolis). The assays were 
performed according to the manufacturer’s instructions.
statistical analyses
Statistical analyses were performed using SPSS version 17.0 
software (SPSS Inc., Chicago, IL, USA). The data were normally 
distributed and significant differences were determined by apply-
ing one-way ANOVA with post hoc Tukey’s test or Fisher’s least 
significant difference test. In every case, P-values <  0.05 were 
considered statistically significant. Principal component analysis 
(PCA), as a descriptive/exploratory technique, was used in order 
to reveal relationships between the variables. Further interpreta-
tions of any relationships among strains, cytokine and leptin lev-
els, and Ob-Rb expression were obtained using PCA and Pearson 
correlation coefficients. PCA analysis was performed using the 
software XLSTAT (18.06).
resUlTs
Differential secretion Pattern of 
cytokines/chemokine induced by 
Different laB in Macrophages
Results in Figure  1 show the ability of viable LAB to induce 
cytokines/chemokine production in macrophages. Production of 
TNF-α and IL-6 (pro-inflammatory cytokines), IL-10 (regulatory 
cytokine), and MCP-1 (pro-inflammatory chemokine) by mac-
rophages stimulated with several strains was determined. Large 
differences in the inflammatory profile among surveyed strains 
were observed. These results showed that the inflammatory 
property is strain-dependent. All strains induced lower secretion 
of pro-inflammatory and regulatory cytokines and chemokine 
than positive control.
Tumor necrosis factor alpha showed values lower than LPS 
stimulus (positive control), with exception of CRL1063 strains. 
CRL66 and CRL575 produced the lowest TNF-α secretions 
(Figure 1A). The highest secretion of IL-6 was observed when the 
cells were stimulated with strain CRL1434. Intermediate values 
of IL-6 were observed with CRL66, CRL431, CRL1063, CRL576, 
CRL575, and CRL372 strains, while with CRL1446, CRL117, 
CRL72, CRL350, CRL353, CRL355, and CRL143 strains, the 
lowest values of IL-6 were obtained (Figure  1B). In addition, 
CRL 1063 induced the highest production of MCP-1 followed by 
CRL431, CRL72, CRL352, and CRL143 (Figure 1C). Regarding 
anti-inflammatory cytokine IL-10, the highest levels were obtained 
in cells stimulated by strains CRL1434 and CRL575, followed by 
strains CRL1063, CRL72, CRL350, and CRL143 (Figure 1D).
The PCA (Figure  1E) revealed an association between 
strains into four different groups, according to the inflammatory 
mediators induced. The cluster I included the CRL355, CRL353, 
CRL350, CRL576, CRL66, and CRL575 strains. This cluster 
also comprises the negative control that represents the baseline 
cytokine secretion, which is positioned far from other strains with 
a lower inflammatory profile. The cluster II included the CRL117, 
CRL1446, CRL72, CRL431, and CRL352 strains and in the cluster 
III, CRL1063 was very closely located in the limit between quad-
rants II and III. The cluster IV only included the strain CRL1434 
with a high inflammatory profile next to LPS stimulus (positive 
control), since this stimulus produced the highest inflammatory 
cytokine secretion compared to all studied strains.
expression of the Ob-rb on Macrophage 
raW 264.7
The influence of different LAB strains on Ob-Rb (leptin recep-
tor) expression in macrophages is shown in Figure  2. Basal 
Ob-Rb expression was detected in approximately 7.5% of control 
macrophages (106 cells; negative control or non-stimulated cells; 
Figures 2A,B). Cells were subsequently stimulated during 24 h 
by either different LAB or LPS (control positive). Ob-Rb-positive 
cells increased to a maximum value of about 38% after LPS stimu-
lation, while the percentages of LAB-stimulated macrophages 
positive for Ob-Rb were lower, except for CRL1434. Levels of 
Ob-Rb expression diverged among different LAB stimuli. The 
most significant increase in the percentage of Ob-Rb (+) cells 
was observed when strain CRL1434 was used as stimulus. The 
strains CRL66 and CRL1063 induced similar Ob-Rb expression 
to positive control. CRL1446, CRL431, CRL576, CRL575, and 
CRL143 strains increased the positive macrophages compared 
to the basal control. For the other studied LAB strains, no sig-
nificant changes in Ob-Rb expression were observed compared to 
negative control. The qualitative immunohistochemistry analyses 
were also performed in macrophages (Figure 2C).
A B
C
E
D
FigUre 1 | Production of tumor necrosis factor alpha (TnF-α), interleukin 6 (il-6), monocyte chemoattractant protein-1 (McP-1), and il-10 by raW 
264.7 cells stimulated with different lactic acid bacteria (laB) strains. Cytokines/chemokine and leptin concentrations were assayed in supernatants from 
LAB-stimulated RAW 264.7 cells. Macrophages were treated for 24 h with bacterial cell suspensions, and TNF-α (a), IL-6 (B), MCP-1 (c), and IL-10 (D) levels were 
quantified using cytometric bead array kit and leptin levels, using enzyme-linked immunosorbent assay test. Purified lipopolysaccharide from Escherichia coli was 
used as a positive control. Non-stimulated cells were evaluated as controls of basal cytokine levels (negative control). The stimulating strains were CRL431, CRL258, 
CRL1063, CRL66, CRL72, CRL117, CRL1446 CRL1434, CRL350, CRL352, CRL353, CRL355, CRL575, and L. CRL576 strains. Results are expressed as 
mean ± SD of triplicate measures determined in two independent experiments. Mean values in the same graphic with different letters (a–d) were significantly 
different (P < 0.05). The relationships among strains, cytokines/chemokine wer obtained using (PCA) and Pearson correlation coefficients. In the biplot obtained by 
PCA (e), points are coded by stimulating strains and controls. The position of some points was slightly modified to avoid overlapping of the labels.
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AFigUre 2 | continued
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Differential Production of and cytokines/
chemokine and leptin in adipocytes 
stimulated with Different laB strains
To evaluate whether LAB may directly induce secretion of 
leptin, cytokines, and chemokine in adipocytes, we stimulated 
murine adipocyte cultures with several strains. We observed 
different effects of LAB on TNF-α, IL-6, IL-10, and MCP-1 
adipocyte production. The CRL1434 strain induced the highest 
values of TNF-α; MCP-1 and IL-10 compared to the other strains 
(Figures  3A,C,D), while CRL350 strain induced the highest 
levels of IL-6 (Figure 3B).
As shown in Figure  3E, leptin production is modulated by 
LAB in a strain-dependent manner. We showed that LPS was 
able to induce a significantly higher leptin production compared 
to negative control. Similar effect was observed for CRL66 and 
CRL575 strains. The CRL1434 and CRL143 strains induced 
more leptin production than positive control. In contrast, lower 
levels of leptin secretion were secreted by adipocytes treated 
with the CRL431, CRL1063, CRL72, CRL355, and CRL352 
strains compared to negative control. Leptin levels produced by 
adipocyte stimulated with CRL1446, CRL117, CRL350, CRL576, 
and CRL353 strains were significantly from those detected in the 
negative and positive controls.
BC
FigUre 2 | leptin receptor (Ob-rb) expression in raW 264.7 cells. RAW 264.7 cells after lactic acid bacteria (LAB) stimulation were incubated with a 
polyclonal rabbit antimouse Ob-Rb Ab and a secondary FITC-conjugated Ab (antirabbit IgG). Ten thousand cells were analyzed per sample at an argon laser flow 
cytometry scanner. (a) Histograms correspond to the analysis of Ob-Rb expression by non-stimulated (negative control) and LAB-stimulated RAW 264.7 cells. The 
stimulating strains were CRL431, CRL258, CRL1063, CRL66, CRL72, CRL117, CRL1446 CRL1434, CRL350, CRL352, CRL353, CRL355, CRL575, and CRL576. 
Lipopolysaccharide (LPS) was used as a positive control. Open black line represents fluorescent labeling of Ob-Rb positive cells of negative control, and gray areas 
represent other strains stimulus. (B) Percentage of Ob-Rb expression in RAW 264.7 cells. The bars represent the different LAB strains. The results are expressed as 
media of percentages of cells Ob-Rb (+) ± SD of two experiments. Mean values in the same graphic with different letters (a–d) were significantly different (P < 0.05). 
(c) Microphotograph representative of the Ob-Rb expression in non-stimulated macrophages (negative control, C-1) and LPS-stimulated macrophages culture 
(positive control, C-2).
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Differential Production of cytokines/
chemokine and leptin by cocultured 
cells (adipocytes and Macrophages) 
stimulated with Different laB strains
To assess whether LAB may directly induce production of TNF-
α, IL-6, MCP-1, IL-10, and leptin by the macrophage–adipocyte 
coculture, we stimulated these cells with the bacterial strains 
(Figure 4). Different effects of LAB on cytokine production in 
the cell coculture were observed (Figures  4A–D). All strains 
induced lower cytokines production than positive control. The 
CRL1434 strain was the most effective stimulating both inflam-
matory (TNF-α, IL-6, and MCP-1) and anti-inflammatory 
(IL-10) cytokines secretion. The CRL431, CRL1063, CRL72, 
CRL355, and CRL352 strains induced significantly higher TNF-
α values than CRL1446, CRL66, CRL350, CRL576, CRL353, 
CRL575, and CRL143 (Figure 4A). Regarding IL-6 production, 
almost all strains induced intermediated levels between positive 
and negative controls (Figure 4B). The CRL431 strain was the 
most potent inductor of MCP-1 secretion (Figure 4C), mean-
while CRL1434 strain was the best inductor of IL-10 secretion 
(Figure 4D).
A B
C D
E
FigUre 3 | Production of TnF-α (a), interleukin 6 (il-6) (B), monocyte chemoattractant protein-1 (McP-1) (c), il-10 (D), and leptin (e) by lactic acid 
bacteria (laB)-stimulated mice adipocytes. Cytokines/chemokine and leptin concentrations were assayed in supernatants from LAB-stimulated mice 
adipocytes. Adipocytes were treated for 24 h with bacterial cell suspensions, and TNF-α, IL-6, MCP-1, and IL-10 levels were quantified using Cytometric Bead Array 
Kit and leptin levels, using enzyme-linked immunosorbent assay test. LPS was used as a positive control. Non-stimulated cells were evaluated as controls of basal 
cytokine levels (negative control). The stimulating strains were CRL431, CRL258, CRL1063, CRL66, CRL72, CRL117, CRL1446 CRL1434, CRL350, CRL352, 
CRL353, CRL355, CRL575, and L. CRL576 strains. Results are expressed as mean ± SD of triplicate measures determined in two independent experiments. Mean 
values in the same graphic with different letters (a–g) were significantly different (P < 0.05).
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A B
C
E
D
FigUre 4 | Production of tumor necrosis factor alpha (TnF-α), interleukin 6 (il-6), monocyte chemoattractant protein-1 (McP-1), il-10, and leptin by 
macrophage/adipocyte coculture stimulated with lactic acid bacteria (laB) strains. Cytokines/chemokine and leptin concentrations were assayed in 
supernatants from LAB-stimulated macrophage/adipocyte coculture. Cells were treated for 24 h with bacterial cell suspensions and TNF-α, IL-6, MCP-1, and IL-10 
levels were quantified using Cytometric Bead Array Kit and leptin levels, using enzyme-linked immunosorbent assay test. LPS was used as a positive control. 
Non-stimulated cells were evaluated as controls of basal cytokine levels (negative control). The stimulating strains were CRL431, CRL258, CRL1063, CRL66, 
CRL72, CRL117, CRL1446 CRL1434, CRL350, CRL352, CRL353, CRL355, CRL575, and L. CRL576 strains. Results are expressed as mean ± SD of triplicate 
measures determined in two independent experiments. Mean values in the same graphic with different letters (a–i) were significantly different (P < 0.05). Production 
levels of (a) TNF-α, (B) IL-6, (c) MCP-1, (D) IL-10, and (e) leptin.
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FigUre 5 | Biplots obtained by principal component analysis (Pca) of cytokines/chemokine and leptin production by macrophage/adipocyte 
coculture associated with expression of the Ob-rb receptor in macrophages. Levels of TNF-α, IL-6, MCP-1, IL-10, and leptin produced by macrophage/
adipocyte cocultures were associated with the expression of Ob-Rb in macrophages in biplots obtained by PCA. Non-stimulated cells were evaluated as controls 
basal (negative control) of cytokines/chemokine and leptin levels and Ob-Rb expression. LPS was used as a positive control. In the biplots, points are coded by 
stimulating strains (CRL431, CRL258, CRL1063, CRL66, CRL72, CRL117, CRL1446 CRL1434, CRL350, CRL352, CRL353, CRL355, CRL575, and L. CRL576) 
and controls. The position of some points was slightly modified to avoid overlapping of the labels.
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Leptin production was also modulated by LAB in a strain-
dependent manner. The CRL17, CRL66, CRL431, CRL1434, 
CRL576, CRL355, CRL575, CRL352, and CRL143 strains induced 
similar levels of leptin than positive control. Other group of 
strains (CRL1446 and CRL350) induced mid-levels of leptin. The 
CRL1063, CRL72, and CRL353 strains did not induce significant 
changes in leptin production compared with negative control.
associations between strain and 
inflammatory Profile, expression of the 
Ob-rb (Macrophage), and leptin 
Production (adipocyte)
Figure 5 shows the PCA plots with focus on grouping of LAB 
with respect to cytokines and leptin produced by macrophage–
adipocyte coculture, both associated with expression of the 
Ob-Rb in RAW 264.7 macrophages. PCA revealed the presence 
of different groups of LAB with significant biological correla-
tion (Figure 5) according to the studied variables. The analysis 
clearly discriminated between LAB with different capacity for 
modulating adipokine production. The analysis revealed that 
two components can be extracted, which together accounted for 
87.31% of the variability. However, the first component accounts 
for 71.33% of the variance and discriminated better the LAB 
according to their capacity for modulating adipokine production 
and was more influenced by TNF-α and MCP-1; however, all 
variables were positively correlated. Second component separates 
better the strains with regard to their influence on leptin and IL-6 
levels. So, the first and second factors discriminate LAB strains 
in four clusters according to their inflammatory profiles, leptin 
(from adipocyte to macrophage) production and leptin receptor 
expression (only in macrophages).
In the cluster I, we observed strong correlations between the 
CRL72, CRL1063, and CRL353 strains. This group also comprises 
the negative control (basal control). The cluster II includes 
CRL1446, CRL66, CRL575, CRL143, CRL350, and CRL117 
strains. The cluster III includes the CRL352, CRL576, CRL355, 
and CRL431 strains. The CRL1434 strain close to positive con-
trol (LPS control) was located in the cluster IV. Stimulus with 
CRL1434 strain induced the highest inflammatory cytokine levels 
compared to the other strains studied.
DiscUssiOn
This study supports the hypothesis that LAB have capacity to 
induce adipokine secretion in strain-dependent manner, and 
this ability is related to their immune properties. This report also 
provides additional evidence for the role of leptin in the regula-
tion of the immune system and the cytokine network. In addition, 
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we showed a strategy of in vitro selection of immunobiotic strains 
(immunoregulatory probiotics) to prevent or improve immuno-
metabolic alterations associated with malnutrition.
The mechanisms by which commensal bacterial strains 
(particularly lactobacilli and bifidobacteria) may confer health 
benefits on the host’s health have been extensively studied (15). 
LAB are known to exert a wide range of effects on the immune 
and endocrine systems and, therefore, potentially in the whole 
body metabolism. However, these effects may be strain-specific 
and properties of one strain cannot be extrapolated to another 
even if belonging to the same species (44). Several beneficial 
microorganisms, generally known as immunobiotics (38), have 
been investigated for their potential use to treat or prevent nutri-
tional disorders (undernutrition and obesity), which are further 
associated with immune deregulation (17, 21, 38, 45, 46).
Obesity induces low-grade inflammation characterized by 
chronic elevations in circulating inflammatory cytokines and 
adipokines (47, 48). Adipose tissue is constituted by active endo-
crine cells that secret a number of adipokines, which play pivotal 
roles in the regulation of various physiological and pathological 
processes in which adipose tissue is involved (49). At the adipose 
tissue level, inflammatory pathways are induced due in part to 
dynamic quantitative and phenotypic changes in adipose tissue 
leukocytes, principally macrophages (48, 50). According to 
Weisberg et al. (39), in mouse models, macrophage content could 
increase to about 50% of total non-adipocyte cells in obese mice. 
Macrophages infiltrated in white adipose tissue are the principal 
source of IL-6 and TNF-α (51). TNF-α is a pro-inflammatory 
cytokine, which has also been implicated as a mediator in induc-
tion of insulin resistance and adipose tissue inflammation (52). 
IL-6 has long been regarded as a pro-inflammatory molecule, but 
recent findings suggest that it also has many anti-inflammatory 
effects (53). IL-10 is a strong anti-inflammatory cytokine due 
to its ability to suppress the release of TNF-α and IL-1b from 
macrophages. In addition, IL-10 would affect Th1-lymphocyte 
actions (54). Regarding this, it was suggested that the C-C 
chemokine receptor 2 and its ligand CCL2 or MCP-1 are neces-
sary for accumulation of inflammatory macrophages (39).
The results showed in this work indicate that adipocyte–
macrophage coculture could be used for the screening and the 
selection of new immunobiotic strains, with the potential to 
functionally modulate adipose inflammation when orally admin-
istered. On the other hand, several authors have demonstrated 
that the gut microbiota could be modified by oral administration 
of LAB, and it has been identified as an important modifier of 
systemic inflammatory reactions influencing remote tissues (21). 
In addition, it is important to mention that there is no direct 
contact between intestinal bacteria and adipose tissue, but this 
FigUre 6 | Possible inmuno- and adipokine modulation of lactic acid bacteria in an in vitro macrophage/adipocyte system.
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contact could be indirectly mediated through translocation of 
bacterial products (e.g., LPS, DNA, etc.), which reach peripheral 
tissues and can stimulate innate immune receptors such as the 
mammalian toll-like receptors (TLRs) (55, 56). TLRs are germ 
line-encoded receptors expressed by cells of the innate immune 
system, adipocytes or intestinal epithelia, which are stimulated by 
structural motifs characteristically expressed by bacteria, viruses, 
and fungi known as pathogen-associated molecular patterns (57). 
Food-derived fatty acids, as well as intestinal bacteria-derived 
fatty acids could be sensed by TLRs, resulting in activation of 
the immune system (55). Taking this into account, we and other 
authors suggested that disruption of the mucosal barrier, as 
occurs in obesity and or undernutrition, leads to the exposure of a 
multitude of commensal-derived TLR ligands that could interact 
with TLR-expressing immune cells and adipocytes (55, 56). Batra 
et  al. (58) demonstrated that expression and responsiveness of 
TLRs (TLR 1–9) in murine preadipocytes and adipocytes are both 
strongly regulated by leptin. This, coupled with the demonstrated 
pro-inflammatory actions of leptin in a variety of immune cells 
and other cell types (59), led us to propose that inflammatory 
responses could be regulated by leptin-modulating strains.
Adipose tissue consists of active endocrine cells that secrete 
a large number of adipokines, mainly leptin, adiponectin, and 
inflammatory cytokines such as TNF-α, IL-6, IL-1, IL-10, and 
MCP-1. These factors play a key role in the regulation of various 
physiological and pathological processes in which adipose tissue 
is involved (49, 60). For this purpose, we evaluated the ability of 
LAB to induce changes in the secretion of adipokines, cytokines, 
and chemokines involved in metabolic inflammation (IL-6, 
IL-10, TNF-α, MCP-1, and leptin), macrophages and adipocytes. 
Main cells that compose the adipose tissue (6, 61).
In order to establish the influence of cross talk between 
the main cells of adipose tissue, a coculture technique using 
macrophages and adipocytes was developed. According to 
Aravindhan and Madhumitha, metainflammation is due to the 
dysfunction of the immune system: at optimal level it confers 
protection against pathogens; at the suboptimal level it leads to 
immunodeficiency; and at supraoptimal level it leads to inflam-
mation (62). Taking this into account, it is necessary to know the 
inflammatory profile of potential probiotic LAB. In this study, 
we first examined the ability of LAB to induce the production of 
different pro-inflammatory and anti-inflammatory responses in 
murine macrophage cell line, since the high infiltration of adipose 
tissue by macrophages occurs in obesity (39–41). Macrophages 
are phagocytic cells that participate in the innate and adaptive 
immune system. They are also one of the major cells that are in 
contact with the microorganisms in the intestine (63). This con-
tact can be performed by phagocytosis or by recognition through 
different receptors, such as those PMAMs, including TLRs. In 
addition to the intestine, macrophages are found in various tis-
sues, being one of the main immune cells of the visceral adipose 
tissue, in both lean and obese subjects, where they can represent 
between 5 and 60% of the immune cells of the adipose tissue 
(64, 65).
In the metabolic disorders, the number and level of activation 
of macrophages are altered (66), so that metabolic parameters, 
such as insulin resistance associated, may be affected (67) or the 
response to infections associated with malnutrition (68, 69). The 
main reason is due to the level of dynamic polarization between 
classically activated macrophages M1 (producers of pro-inflam-
matory cytokines) and alternatively activated macrophages M2 
(anti-inflammatory cytokine producers) present in the adipose 
tissue (6). The level of activation is associated with a particular 
cytokine profile, and this is dysregulated in metabolic disorders 
(70). We demonstrated large differences in the inflammatory 
profile among evaluated strains, suggesting that the inflammatory 
property is strain-dependent, and different functional roles could 
be played by studied strains. We showed, in and other work, dif-
ferent cytokine profiles produced by macrophages induced by lac-
tobacilli, bifidobacteria, and bacteroides strains (21, 71). Similar 
observations were previously reported by Medina et  al. (72). 
These authors demonstrated different abilities of Bifidobacterium 
strains to modulate in vitro production of cytokines by PBMCs, 
suggesting that they could drive immune responses in different 
directions. Maassen et al. (73) showed that different Lactobacillus 
strains induce distinct mucosal cytokine profiles and possess dif-
ferential intrinsic adjuvant properties. These authors suggested 
that rational Lactobacillus strain selection provides a strategy to 
influence cytokines expression and thereby influence immune 
responses. Considering only our results of inflammatory profile 
in macrophages, strains such as CRL72, CRL1446, CRL352, 
CRL431, and CRL117 with a medium inflammatory profile could 
provide protection against the early stage of infection via Th1 
with TNF-α and IL-6 production (74).
According to Jaedicke et al. (59), increased leptin concentra-
tions in obesity may drive monocytes into a more activated, 
macrophage-like, pro-inflammatory state, possibly by affecting 
expression of TLRs and CD14, thereby enhancing LPS responsive-
ness and contributing to increased inflammation. Furthermore, 
knowing that leptin enhances T cell proliferation and Th1 pro-
inflammatory cytokine production in vitro (31), we proceed to 
evaluate leptin and cytokines production by adipocytes in mono 
and coculture and the presence of a functional Ob-Rb (leptin 
receptor) in macrophages. Other authors showed that bacterial 
strains have different ability to modulate leptin secretion by 
adipocytes (26, 75, 76).
We evaluated whether Ob-Rb expression is regulated during 
macrophage activation by different LAB strains. Ob-Rb positive 
cells increased after LPS stimulation (positive control) and its 
expression diverged among different LAB stimuli. A previous 
study demonstrated that macrophages and B and T lymphocytes 
constitutively express low levels of Ob-Rb, and that this expression 
is upregulated, in terms of both percentage of positive cells and 
receptor density, in response to activation of these immune cells 
(31). We observed that “more inflammatory” strains produced 
more leptin as well as increased Ob-Rb receptor expression on 
macrophages, which is according to the notion of pro-inflamma-
tory property of leptin and its adverse role in obesity (28).
Stimulating adipocytes/RAW264.7 cells with LAB results 
in marked upregulation of cytokine and leptin production in 
comparison with an adipocyte culture. Other authors, using the 
coculture system, showed inhibition of the cycle of stimulation 
of adipocytes and macrophages through the inhibition of mac-
rophage-mediated pro-inflammatory cytokines and upregulation 
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of adiponectin in adipocytes (77). These favorable effects may 
suppress chronic inflammation in adipose tissue. De Palma et al. 
also demonstrated, in another coculture system (PBMC and Caco 
cells), that some microorganisms had different behavior (cytokine 
production) using individual cell cultures (78). Furthermore, we 
observed significant production of IL-6 and MCP-1 in a coculture 
compared to the effect in macrophage cells; these two molecules 
are related to macrophage infiltration and insulin resistance in 
adipose tissue (40, 79). In addition, it is estimated that between 
15 and 35% of the systemic IL-6 levels come from adipose tissue 
in obese individuals (79).
In our study, we used viable LAB strains and observed a 
modulation, strain dependent, on the production of leptin in adi-
pocytes in mono- and coculture with macrophages. However, like 
other authors, we suggest that mediators produced by other cells 
in adipose tissue, such as macrophages, influence the secretory 
capacity of adipocytes and vice versa, because of the difference 
in the secretion of leptin, cytokines, and chemokine, comparing 
mono- and coculture (80, 81).
We observed that CRL431 strain showed a significant reduc-
tion in leptin levels compared to control (—), when adipocytes 
were stimulated, but significantly higher levels than LPS in mac-
rophage–adipocyte–LAB coculture. A similar pattern occurred 
with strain CRL1434, which showed significantly higher leptin 
levels of LPS by stimulating adipocytes, but in the coculture 
system it presented values similar to LPS. This clearly reflects the 
intercommunication between these two cells (macrophages and 
adipocytes) and that LAB can affect the production of adipokines 
in this system.
In order to determine an association between the different 
strains, regarding their inflammatory profile, Ob-Rb receptor 
induction and their effect on leptin production, the PCA was car-
ried out. In this study, CRL355, CRL431, CRL576, and CRL352 
strains that induced high levels of leptin could be exploited in 
diseases with low concentrations of leptin. On the contrary, 
downregulation of circulating leptin levels may be considered 
as possible strategy to intervene on some inflammatory and 
autoimmune conditions (28). In the latter situation, strains such 
as CRL117, CRL350, CRL143 CRL575, CRL1446, and CRL66 
could be useful. Miyazawa et  al. demonstrated that increased 
pro-inflammatory cytokines (IL-6, IL-12, and TNF-α) inhibited 
the differentiation of a fibroblast cell line (3T3L1) in adipocytes, 
suggesting that acute inflammation stimulated by lactobacilli 
could be the mechanism by which adipogenic differentiation is 
suppressed, leading to adipocyte hypertrophy (33).
We suggest that the CRL575, CRL143, CRL117, CRL352, 
CRL576, CRL355, CRL431, and CRL1434 strains that induce 
high levels of leptin (either in adipocytes or in the Mac-Adi-BL 
system) could be oriented to the use in nutritional therapies for 
diseases that occur with reduced levels of leptin. In an opposite 
case, decreased levels of this adipokine would be necessary for the 
intervention of inflammatory or autoimmune pathologies (28), 
where CRL72, CRL66, and CRL1446 strains could be used.
It is noteworthy that CRL1446 strain induced a decline in 
leptin production. This strain has antioxidant, hypoglycemic, 
and hypocholesterolemic properties in animal studies (23, 82), 
thereby could be an interesting alternative for treating obesity, 
which is characterized by high leptin levels. CRL431 strain, which 
is a probiotic microorganism that demonstrated positive immu-
nological effects in undernourished hosts (17, 38), was located, 
in the PCA analysis, next to strains that induced middle leptin 
production. Other authors showed the specific effect of LAB on 
the response of porcine adipocytes to TNF-α stimulation using 
conditioned media from LAB-stimulated intestinal immune cells 
(32). They suggested that lactobacilli may suppress differentiation 
of preadipocytes through macrophage activation and production 
of Th1 cytokines and could be effective in improving Th1 response 
not only in the gut but also in the systemic compartment as well. 
Then, our data show that different LAB strains could be capable 
of regulating adipokine expression in adipose tissue and suggest 
that they could have the potential to functionally modulate adi-
pose inflammation when orally administered.
We conclude that macrophage/adipocyte coculture is the most 
appropriate system for the selection of strains with the ability to 
modulate cytokine and leptin secretion. Our results showed that 
a stimulation of adipocyte monoculture with LAB strains exerts 
different effects than those observed in macrophage/adipocyte 
cocultures. This could be explained by the strong relationship 
between macrophages content and adipocytes in the adipose 
tissue, which boosts production of pro-inflammatory molecules 
and acute-phase proteins associated with obesity. Therefore, the 
regulation of TNF-α, IL-6, MCP-1, IL-10, and leptin and Ob-Rb 
receptor could be considered as biomarkers for immunobiotic 
strains. The use of microorganisms with low and middle inflam-
matory properties and ability to modulate leptin levels could be a 
strategy for the treatment of some metabolic diseases associated 
with immune abnormalities. In Figure  6, we show the pos-
sible inmuno- and adipokine modulation of LAB in an in vitro 
adipocyte system. This approach could be easily applicable in 
obesity and immune-deficient conditions like undernutrition. 
So, preclinical studies are currently being developed with the oral 
administration of CRL1446, CRL1434, and CRL431 (selected LAB 
in this work) in different experimental models of malnutrition 
(data no showed). The elucidation of the mechanisms involved in 
the modulation of adipose inflammation by LAB strains requires 
further studies associated with Ob-Rb and TLR expression.
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